From the aDepartment of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC
bDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA
cDivision of Adolescent Medicine, Nationwide Children’s Hospital, Columbus, OH
dDepartment of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH
eDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH
fDepartment of Statistical Sciences, College of Arts and Sciences, Wake Forest University, Winston-Salem, NC.
Submitted September 15, 2022; accepted March 20, 2023
Data accessibility: The authors do not have permission to share treatment admission data used in this study. The data are available via data use agreement with the Ohio Department of Mental Health and Addiction Services. Overdose death, HCV, and HIV data are publicly available from the Ohio Department of Health. Computer code for the analysis is available online.
Supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number R01DA052214.
The authors report no conflicts of interest.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).
Correspondence: David Kline, Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157. E-mail: [email protected].
